Brown Rudnick Advises EDX Medical in Acquisition of Hutano Diagnostics

Brown Rudnick Advises EDX Medical in Acquisition of Hutano Diagnostics

Brown Rudnick, an international law firm representing clients around the world, has advised EDX Medical Group on its share-for-share acquisition of Oxford-based Hutano Diagnostics Ltd. The deal was originally announced on September 27, but Brown Rudnick’s involvement in the transaction wasn’t announced until October 10.  Hutano Diagnostics is a start-up developing a diagnostic and surveillance platform for diseases caused by emerging and dangerous pathogens that cause recurring epidemics in Africa. The company is currently developing an Ebola diagnostic and surveillance platform.  Founded in 2022, EDX Medical is a developer of digital diagnostic products and services for the... Read More »
LabGenomics USA Acquires QDx Pathology 

LabGenomics USA Acquires QDx Pathology 

LabGenomics USA announces its acquisition of Edison, New Jersey-based QDx Pathology Services.  QDx Pathology Services is an independent, full-service molecular and anatomical pathology laboratory in Edison, New Jersey. The company was founded in 2006.   LabGenomics USA, a subsidiary of South Korea-based LabGenomics Co., Ltd., is a healthcare company specializing in molecular diagnostics.  It is based in Fountain Valley, California.  The acquisition is expected to have significant implications for the future of both companies and the industry, according to the press release. The financial terms of the acquisition were not disclosed.  According to data captured in... Read More »
Brown Rudnick Advises EDX Medical in Acquisition of Hutano Diagnostics

Danaher Corporation Acquires Abcam plc for $5.7 Billion

Danaher Corporation announced on August 28 that it has entered into a definitive agreement to acquire Abcam plc. According to data captured in the LevinPro HC database, this acquisition represents the 94th Laboratories, MRI and Dialysis transaction of 2023.  Danaher will acquire all the currently outstanding shares of Abcam at a price of $24.00 per share in cash. In total, this acquisition is valued at approximately $5.7 billion, which factors in assumed debts and deducts acquired cash.  Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its products include primary and secondary antibodies, proteins, peptides, lysates,... Read More »
LabGenomics USA Acquires QDx Pathology 

Solis Mammography Acquires Carolina Breast Imaging Specialists  

Solis Mammography, based in Addison, Texas, announced its acquisition of Carolina Breast Imaging Specialists for an undisclosed price.   For more than 10 years, Carolina Breast Imaging Specialists has been providing patients care through a team of fellowship trained breast imaging specialists and state-of-the-art technology. It has three locations in North Carolina: Greenville, Goldboro and Wilson.   Solis Mammography, a portfolio company of Madison Dearborn Partners since August 2018, is one of the largest independent providers of mammography and breast health services in the United States. It has more than 70 centers and has performed more than 5 million procedures. ... Read More »
LabGenomics USA Acquires QDx Pathology 

PE-Backed Transnetyx Acquires Laragen 

On August 23 Transnetyx, Inc., based in Cordova, Tennessee, announced its acquisition of Laragen, Inc. The financial terms were not disclosed.  Laragen is a sequencing and genetic services company in Culver City, California. The company was founded in 1995.   Transnetyx, a portfolio company of Thompson Street Capital Partners, is a fully-automated genotyping resource for thousands of researchers in universities, hospitals and bioscience companies around the world. It has genotyped more than 20 million samples in 24 or 72 hours with 99.97% accuracy.  The addition of Laragen’s sanger sequencing and next-generation sequencing services to the Transnetyx solution suite will... Read More »
PE-Backed STARLIMS Acquires Labstep

PE-Backed STARLIMS Acquires Labstep

STARLIMS, backed by Francisco Partners, announced on August 22 its acquisition of Labstep for an undisclosed price. According to data captured in the LevinPro HC database, this acquisition represents the 92nd Laboratories, MRI and Dialysis transaction of 2023  Labstep is a modern R&D cloud platform helping customers unlock the power of real-time data. Found in more than 900 universities and more than 65 companies worldwide, Labstep’s Electronic Laboratory Notebook (ELN) platform streamlines laboratory work, delivers real-time data capture and collaboration and enhances data integrity.  STARLIMS provides enterprise informatics solutions and is committed to providing quality... Read More »